Results 271 to 280 of about 4,347,639 (355)

1077 Defining immune selection-driven neoantigen evolution to optimize cancer vaccine targets [PDF]

open access: gold
Mariam Mathew George   +9 more
openalex   +1 more source

Genetic variants of EcPV2 E6 and E7 in equine genital and oronasal squamous cell carcinoma

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Background Since its discovery in 2008, equine papillomavirus type 2 (EcPV2) has been detected in up to 100% of equine genital and up to 40% of equine oronasal squamous cell carcinomas (SCCs). Preliminary sequence data point to the existence of EcPV2 E6 and E7 oncogene variants compared to the British reference sequence from 2008.
Maya Jenner, Sabine Brandt
wiley   +1 more source

128 Molecular mimicry in the dark immunopeptidome: viral-homologous non-canonical tumor peptides as targets for off-the-shelf cancer vaccines [PDF]

open access: gold
Angela Mauriello   +6 more
openalex   +1 more source

Autonomous Nanomedicine: Closing the Biological Validation Gap

open access: yesExploration, EarlyView.
Delivery of nanoparticles to tumors has not improved in over fifteen years, and biological testing remains slow and separate from formulation design. This review proposes adding a Biology step to the design cycle, using organ chips and patient‐derived organoids, and assesses the readiness of each required technology.
Yan Jun Lin, Izabella Komperda
wiley   +1 more source

Recombinant adenoviruses application for cancer vaccines: from genetic design to clinical translation. [PDF]

open access: yesFront Oncol
Almarghalani NA   +5 more
europepmc   +1 more source

Data-driven age structured model for optimal control and cost-effective HPV vaccine uptake for cervical cancer reduction in Tanzania

open access: gold
Sylas Oswald   +5 more
openalex   +1 more source

728 Enzalutamide impairs CD8 + T cell activation and does not alter the efficacy of AR-targeted vaccine in prostate cancer models [PDF]

open access: gold
Kaitlyn Marie Schneider   +4 more
openalex   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

open access: yesFlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy